clindamycin and Heart Septal Defects, Ventricular

clindamycin has been researched along with Heart Septal Defects, Ventricular in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asari, S; Fukuyama, M; Hata, A; Hata, D; Iki, Y; Watanabe, K; Yoshioka, T1
Grajek, S; Ozorowski, T; Straburzyńska-Migaj, E; Trojnarska, O; Łanocha, M1

Other Studies

2 other study(ies) available for clindamycin and Heart Septal Defects, Ventricular

ArticleYear
Successful Conservative Treatment of Mycotic Pulmonary Artery Aneurysms Caused by MRSA Bacteremia.
    Pediatrics, 2019, Volume: 144, Issue:5

    Topics: Aneurysm, Infected; Anti-Bacterial Agents; Bacteremia; Clindamycin; Conservative Treatment; Drug Combinations; Drug Therapy, Combination; Echocardiography; Female; Heart Septal Defects, Ventricular; Humans; Infant; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pulmonary Artery; Radiography; Rifampin; Staphylococcal Infections; Sulfamethizole; Trimethoprim

2019
[Effective treatment of recurrent infective endocarditis. Is it always in compliance with the guidelines?].
    Kardiologia polska, 2010, Volume: 68, Issue:2

    Topics: Adult; Aminoglycosides; Aortic Valve; Clindamycin; Endocarditis, Bacterial; Gentamicins; Guideline Adherence; Heart Septal Defects, Ventricular; Heart Valve Prosthesis; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Peptides; Recurrence; Staphylococcal Infections; Vancomycin

2010